SBD

SBD

Science PT ↓ 500 episodes

Acompanhe as últimas novidades sobre o diabetes, tratamentos e muito mais, com os Podcasts da Sociedade Brasileira de Diabetes, exclusivos para profissionais da saúde. Os programas contarão com a participação de grandes diabetologistas brasileiros, comentando artigos nacionais e internacionais, para que você esteja sempre bem informado sobre as últimas tendências.

Author

SBD

Category

Science

Podcast website

www.diabetes.org.br

Latest episode

Jan 9, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 5M+ downloads · 4.8 rating iOS soon

Episodes

P 155 - Efeito da dieta, exercício e fármacos no GLP-1 de DM2 - Andréa Fioretti 22.06.2020

Ref: Relationship Between diet/exercise and Pharmacotherapy to Enhance the GLP-1 Levels in Type 2 Diabetes. Endocrinol Diabetes Metab. 2019 May 16;2(3):e00068.

P 154 - Bypass gástrico vs melhor tratamento clínico em DM2 e obesidade 16.06.2020

Ref: Cohen RV, Pereira TV, Aboud CM, et al. Effect of Gastric Bypass vs Best Medical Treatment on Early-Stage Chronic Kidney Disease in Patients With Type 2 Diabetes and Obesity: A Randomized Clinical Trial. JAMA Surg. Published online June 03, 2020. doi:10.1001/jamasurg.2020.0420

P 153 - Efeito do isolamento social no sedentarismo e DCV - William Valadares 15.06.2020

Ref: Social Isolation During the COVID-19 Pandemic Can Increase Physical Inactivity and the Global Burden of Cardiovascular Disease. Am J Physiol Heart Circ Physiol. 2020 Jun 1;318(6):H1441-H1446.

P152 - Efeito do lockdown na glicemia de DM1 - Laerte Damaceno 08.06.2020

Ref: Glycaemic Control Among People With Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in Italy. Diabetes Ther. 2020 May 11;1-11

P 151 - DM2 magro - Roberto Zagury 02.06.2020

P 151 - DM2 magro - Roberto Zagury by SBD

P 150 - Medicamentos que reduzem risco CV e IC em DM2 - Amélio de Godoy-Matos 02.06.2020

Ref: Glucose-lowering Drugs or Strategies, Atherosclerotic Cardiovascular Events, and Heart Failure in People With or at Risk of Type 2 Diabetes: An Updated Systematic Review and Meta-Analysis of Randomised Cardiovascular Outcome Trials. Lancet Diabetes Endocrinol. 2020 May;8(5):418-435.

P 149 - Mortalidade por COVID-19 em DM1 e DM2 - Melanie Rodacki 25.05.2020

Ref: Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a whole population study E Type 1 and Type 2 diabetes and COVID-19 related mortality in England: a cohort study in people with diabetes  

P 148 - Programas de educação em DM - Gláucia Duarte 19.05.2020

Ref: An Effective Model of Diabetes Care and Education: Revising the AADE7 Self-Care Behaviors®. Diabetes Educ. 2020 Apr;46(2):139-160

P147 - Intensidade do exercício e saúde vascular do DM2 - Denise Maria Martins Vancea 11.05.2020

Ref: Effects of combined training with different intensities on vascular health in patients with type 2 diabetes: a 1-year randomized controlled trial. Cardiovasc Diabetol. 2019 Mar 18;18(1):34.

P 146 - Gerenciamento do DM1 de início recente por telemedicina - Denise Reis Franco 08.05.2020

Ref: Managing New-Onset Type 1 Diabetes During the COVID-19 Pandemic: Challenges and Opportunities. Diabetes Technol Ther. 2020 Apr 17

P 145 - Exercício e neuropatia periférica - William Valadares 04.05.2020

Ref: The Effect of Exercise on Neuropathic Symptoms, Nerve Function, and Cutaneous Innervation in People With Diabetic Peripheral Neuropathy. J Diabetes Complications. Sep-Oct 2012;26(5):424-9

P 144 - Características glicêmicas e desfechos em internados por COVID-19 - Roberto Raduan 27.04.2020

Ref: Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States. J Diabetes Sci Technol. 2020; In press

P143 - Pesquisa psico-comportamental e hipoglicemia em DM1 - Fani Malerbi 24.04.2020

Ref: How Has Psycho-Behavioural Research Advanced Our Understanding of Hypoglycaemia in Type 1 Diabetes? Diabet Med. 2020 Mar;37(3):409-417

P142 - Microbiota e músculo - Roberto Zagury 14.04.2020

Microbiota and muscle highway - two way traffic. Nat Rev Endocrinol. 2020 Feb;16(2):71-72.

P - 141 Bochecho de CHO e ciclismo - Yuri Galeno 06.04.2020

Ref: Effects of Carbohydrate Mouth Rinse on Cycling Time Trial Performance: A Systematic Review and Meta-Analysis. Sports Med. 2019 Jan;49(1):57-66.

P - 140 Telemedicina (COVID-19) e DM - Márcio Krakauer 25.03.2020

P - 140 Telemedicina (COVID-19) e DM - Márcio Krakauer by SBD

P - 139 Isolamento (COVID-19) e DM - Glaucia Margonari Bechara Rodrigues 25.03.2020

P - 139 Isolamento (COVID-19) e DM - Glaucia Margonari Bechara Rodrigues by SBD

P - 138 COVID-19 e DM - Fernando Valente 23.03.2020

P - 138 COVID-19 e DM - Fernando Valente by SBD

P137 - Recomendações atualizadas de exercício físico para DM - Clayton Macedo 10.03.2020

Ref: Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes 2020. Diabetes Care 2020 Jan; 43 (Supplement 1): S48-S65.

P136 - Efeito glicêmico de HIIT e metformina - Ricardo Oliveira 10.03.2020

Ref: Exercise improves metformin 72-h glucose control by reducing the frequency of hyperglycemic peaks. Acta Diabetol. 2020 Feb 4.

P135 - Monitorização glicêmica por sensor no Brasil e no mundo - Luis Eduardo Calliari 31.01.2020

Ref: Real-world flash glucose monitoring in Brazil: can sensors make a difference in diabetes management in developing countries? Diabetol Metab Syndr. 2020 Jan 7;12:3.

P134 - CGM impacta mais que método de insulinizar DM1 - estudo COMISAIR - Carla Bergamin 19.12.2019

Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study. Diabetes Care. 2019 Sep 17.

P133 - Manejo do peso e remissão do DM2 - estudo DIRECT - Suzana Vieira 11.11.2019

Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet. 2018 Feb 10;391(10120):541-551.

P132 - Mortalidade após controle dos fatores de risco DCV no DM2 - Wellington Santana 01.11.2019

Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med. 2018 Aug 16;379(7):633-644

P131 - Intervenção precoce da DCV no DM2 - Fábio Trujilho 25.10.2019

P131 - Intervenção precoce da DCV no DM2 - Fábio Trujilho by SBD

Listen to the SBD podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.